Evidence map›Paper›PMID 39074259›Full record

ArticleProtein science : a publication of the Protein Society2024

Stable and reusable calcium-responsive biopolymer for affinity precipitation of therapeutic antibodies.

Heesun Park, Jeong-Seok Oh, Jonghwan Lee, Jinho Bang, Keunwan Park, Suhyeon Jeong, Seho Park, Jae-Sung Woo, Sunghyun Kim

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Protein science : a publication of the Protein Society, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Heesun ParkCenter for Convergence Bioceramic Materials, Korea Institute of Ceramic Engineering and Technology, Cheongjusi, Chungcheongbuk-do, South Korea.
Jeong-Seok OhDepartment of Life Sciences, Korea University, Seoul, South Korea.
Jonghwan LeeCenter for Convergence Bioceramic Materials, Korea Institute of Ceramic Engineering and Technology, Cheongjusi, Chungcheongbuk-do, South Korea.
Jinho BangCenter for Convergence Bioceramic Materials, Korea Institute of Ceramic Engineering and Technology, Cheongjusi, Chungcheongbuk-do, South Korea.
Keunwan ParkNatural Product Informatics Research Center, Korea Institute of Science and Technology, Gangneung-si, Gangwon-do, South Korea.
Suhyeon JeongCenter for Convergence Bioceramic Materials, Korea Institute of Ceramic Engineering and Technology, Cheongjusi, Chungcheongbuk-do, South Korea.
Seho ParkToolBio Inc, Daejeon, South Korea.
Jae-Sung WooDepartment of Life Sciences, Korea University, Seoul, South Korea.
Sunghyun KimCenter for Convergence Bioceramic Materials, Korea Institute of Ceramic Engineering and Technology, Cheongjusi, Chungcheongbuk-do, South Korea.ORCID 0000-0002-8725-4200

Funding

Korea Institute of Ceramic Engineering and Technology 1415187241Ministry of Science and ICT (MIST) of the Republic of Korea RS-2023-00246123Ministry of SMEs and Startups RS-2023-00257296Samsung Research Funding & Incubation Center SRFC-MA1801-07
6 · The paper itself

Abstract

Affinity precipitation is an attractive method for protein purification due to its many advantages, including the rapid capture of target proteins, simple processing, high specificity, and ease of scale-up. We previously reported a robust antibody purification method using Ca

Indexed as

CalciumAnimalsCalsequestrinChemical PrecipitationCHO CellsCricetulusHumansProtein StabilityRecombinant Fusion ProteinsCalciumCalsequestrinRecombinant Fusion Proteinsantibody purificationcalcium‐dependentcalsequestrincost‐effectivenessprotein engineeringreuseZ‐domain

Identifiers

PMID39074259
PMCPMC11285868

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.